Concepedia

Gintvile Valinciute

GV

4

Publications

124

Citations

4

H-Index

2017

Active since

Affiliations

University Hospital Heidelberg(Current)

Heidelberg University

German Cancer Research Center

Hopp Children's Cancer Center Heidelberg

Gintvile Valinciute is an author at University Hospital Heidelberg specializing in chromatin, radiation oncology, and cell biology.

ORCID

Top concepts

Publications per year

2017–2025

4

Publications

4

Reduced chromatin binding of MYC is a key effect of HDAC inhibition in MYC amplified medulloblastoma

Jonas Ecker, Venu Thatikonda, Gianluca Sigismondo et al. · Neuro-Oncology · 2020 · 61 citations · Full text

BH3 mimetics targeting BCL-XL impact the senescent compartment of pilocytic astrocytoma

Florian Selt, Romain Sigaud, Gintvile Valinciute et al. · Neuro-Oncology · 2022 · 38 citations · Full text

Evaluation of Cereblon-Directing Warheads for the Development of Orally Bioavailable PROTACs

Marisa Actis, Joel O. Cresser-Brown, Elizabeth A. Caine et al. · Journal of Medicinal Chemistry · 2025 · 13 citations

BET-bromodomain inhibitors modulate epigenetic patterns at the diacylglycerol kinase alpha enhancer associated with radiation-induced fibrosis

Gintvile Valinciute, Christoph Weigel, Marlon R. Veldwijk et al. · Radiotherapy and Oncology · 2017 · 12 citations

, , +8

Rows per page

1–4 of 4